Skip to main content
GutCited

N-Acetyl Cysteine (NAC) के लिए Inflammatory Bowel Disease (IBD) — General

D

Pilot data only. Glutathione precursor may reduce oxidative stress in IBD. Requires larger clinical trials.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dn\u002Dacetyl\u002Dcysteine\u0026condition\u003Dinflammatory\u002Dbowel\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

निष्कर्ष

Pilot data only. Glutathione precursor may reduce oxidative stress in IBD. Requires larger clinical trials.

Key Study Findings

Review
Nanocatalytic Antioxidation: A General Chemical Approach for Alleviating Oxidative Stress in Diseases.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: Review of nanocatalytic antioxidation in diseases

Randomized Controlled Trial 16 weeks Open-label
Exploring the role of oxidative stress and the effect of N-acetylcysteine in thiopurine-induced liver injury …
Dose: N-acetylcysteine with thiopurine बनाम: Thiopurine alone (crossover) Outcome: Liver injury markers and oxidative stress प्रभाव: None None

जनसंख्या: IBD patients with thiopurine-induced liver injury

Review
The emerging role of oxidative stress in inflammatory bowel disease.
Dose: None बनाम: None Outcome: Oxidative stress role in IBD pathophysiology प्रभाव: None None

जनसंख्या: IBD patients (Crohn's and UC)

In Vitro 4.3 weeks
Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, and Kidney.
Dose: 150 mg/kg बनाम: None Outcome: inflammation markers प्रभाव: None None

जनसंख्या: Mice

Systematic Review 52 weeks
Vitamin D for the treatment of inflammatory bowel disease.
Dose: 400 IU/day बनाम: placebo Outcome: IBD disease activity प्रभाव: None None

जनसंख्या: Patients with IBD

Review
Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease …
Dose: None बनाम: None Outcome: Ferroptosis role in IBD pathogenesis प्रभाव: None None

जनसंख्या: IBD patients (mechanistic review)

Key Statistics

1

अध्ययन

30

प्रतिभागी

Positive

D

ग्रेड

Referenced Papers

Frontiers in endocrinology 2024 165 उद्धरण
Pharmaceuticals (Basel, Switzerland) 2023 18 उद्धरण
The Cochrane database … 2023 1 उद्धरण
European journal of … 2021 40 उद्धरण
The British journal … 2012 145 उद्धरण
The Tohoku journal … 2005 114 उद्धरण
Laboratory investigation; a … 2000 116 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
600-1,200 mg/day in divided doses
hpyloriadjunct:
600 mg twice daily alongside standard triple therapy
antioxidantsupport:
600-900 mg/day

अधिकतम सीमा: Generally well-tolerated up to 1,800 mg/day; higher doses used in clinical settings

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Mixed --
N-acetylcysteine with thiopurine 16 weeks Positive --
None -- Positive --
150 mg/kg 4.3 weeks Positive --
400 IU/day 52 weeks Mixed --
None -- Neutral --
Various antioxidant compounds -- Positive --
None -- Mixed --

सेवन का सर्वोत्तम समय: With or without food; divide doses throughout the day

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Nausea and vomiting (most common, especially at higher doses)
  • Diarrhea
  • Unpleasant sulfur taste/odor
  • Headache

ज्ञात अंतःक्रियाएँ

  • Nitroglycerin (NAC may enhance vasodilatory effects; risk of hypotension)
  • Activated charcoal (may reduce NAC absorption)
  • Anticoagulants (NAC may have mild antiplatelet effects)
  • ACE inhibitors (additive hypotensive effect with nitroglycerin combination)

सहनीय अधिकतम सेवन: Generally well-tolerated up to 1,800 mg/day; higher doses used in clinical settings

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does N-Acetyl Cysteine (NAC) help with Inflammatory Bowel Disease (IBD) — General?
Based on 1 studies with 30 participants, there is preliminary evidence that needs more research that N-Acetyl Cysteine (NAC) may support Inflammatory Bowel Disease (IBD) — General management. Our evidence grade is D (Very Early Research).
How much N-Acetyl Cysteine (NAC) should I take for Inflammatory Bowel Disease (IBD) — General?
Studies have used various dosages. A commonly studied range is 600-1,200 mg/day in divided doses. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of N-Acetyl Cysteine (NAC)?
Reported side effects may include Nausea and vomiting (most common, especially at higher doses), Diarrhea, Unpleasant sulfur taste/odor, Headache. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for N-Acetyl Cysteine (NAC) and Inflammatory Bowel Disease (IBD) — General?
We rate the evidence as Grade D (Very Early Research). This rating is based on 1 peer-reviewed studies with 30 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Inflammatory Bowel Disease (IBD) — General

N-Acetyl Cysteine (NAC) अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।